- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: ASP3325
Total 20 results
-
Astellas Pharma IncCompletedChronic Kidney Disease | Hyperphosphatemia Undergoing HemodialysisJapan
-
Astellas Pharma IncCompletedPharmacokinetics of ASP3325 in Non-elderly, Healthy Adult Japanese Male and Female, and Caucasian Male SubjectsJapan
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics of ASP3652United Kingdom
-
Astellas Pharma Global Development, Inc.TerminatedAcute Myeloid LeukemiaCanada, United States
-
Astellas Pharma IncTerminated
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics of ASP3652 | Pharmacodynamics of ASP3652United Kingdom
-
Astellas Pharma IncCompletedSolid Tumor | B-Cell Lymphoma | Advanced Malignancies | Positive for Anaplastic Lymphoma Kinase | Positive for Proto-Oncogene Tyrosine-Protein Kinase ROSUnited States
-
Astellas Pharma IncCompleted
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | Pharmacodynamics | Effect of RaceUnited Kingdom
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma IncCompletedChronic Pelvic Pain Syndrome | Chronic Abacterial ProstatitisCzech Republic, Germany, Latvia, Lithuania, Poland, Spain
-
Astellas Pharma Europe B.V.CompletedPain | Urologic Diseases | Cystitis, Interstitial | Urinary Bladder DiseaseBelgium, Czechia, Denmark, Germany, Latvia, Lithuania, Netherlands, Poland, Portugal, Romania, Russian Federation, Spain
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics of ASP3652 | Pharmacodynamics of ASP3652Netherlands
-
Astellas Pharma IncCompleted
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | Pharmacodynamics | SafetyNetherlands
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Drug-Drug Interaction (DDI)United Kingdom
-
Astellas Pharma IncCompletedHealthy VolunteersJapan
-
Astellas Pharma IncCompletedRestless Legs SyndromeJapan
-
Astellas Pharma IncCompletedPatients With Impaired Renal Function and HaemodialysisJapan
-
Astellas Pharma Global Development, Inc.Completed